|
Video: What is a Stock Split?
|
|
NeuroMetrix is a health-care company that develops wearable medical technology and point-of-care tests to manage chronic pain, nerve diseases, and sleep disorders. Co.'s marketed products include: Quell, a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems; SENSUS pain therapy device, a prescription neuro-stimulation device based on TENS for relief of chronic, intractable pain; and DPNCheck, a nerve conduction test used to evaluate systemic neuropathies such as diabetic peripheral neuropathy. Co.'s neurodiagnostics business is based on the ADVANCE NCS/EMG System, a platform for the performance of nerve conduction studies. According to our NUROW stock split history records, NUROW has had 0 splits. | |
|
NUROW (NUROW) has 0 splits in our NUROW stock split history database.
Looking at the NUROW stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into NUROW shares, starting with a $10,000 purchase of NUROW, presented on a split-history-adjusted basis factoring in the complete NUROW stock split history.
NUROW -- use the split history when considering split-adjusted past price performance. |
|
|
|